ArQule is a biopharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of cancer. ArQule was founded in 1993. ArQule's headquarters is located in Burlington, Massachusetts, USA 01803.
ArQule's CEO, Paolo Pucc... ArQule's CEO, Paolo Pucci, currently has an approval
rating of 87%. ArQule's primary competitors are AbbVie, Amgen & Astellas.
There have been no acquisitions found related to ArQule
Recent investment data cannot be found related to ArQule